Etanercept shows efficacy in treating patients with moderate-to-severe plaque psoriasis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1303, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ustekinumab useful for moderate-to-severe plaque psoriasis

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Etanercept effective in paediatric patients with plaque psoriasis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Emerging drugs for moderate-to-severe psoriasis

By Magliocco Melissa A  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 35-52

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of moderate-to-severe psoriasis treatment

By Miller Drew W   Feldman Steven R  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 157-167

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab: A Review of its Use in the Management of Moderate To Severe Plaque Psoriasis

By Croxtall Jamie D.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1733-1753

Adis International

Access to resources Recommend Favorite